Previous close | 0.3000 |
Open | 2.0000 |
Bid | 0.0000 |
Ask | 5.0000 |
Strike | 25.00 |
Expiry date | 2024-07-19 |
Day's range | 0.3000 - 2.0000 |
Contract range | N/A |
Volume | |
Open interest | 3 |
FOSTER CITY, Calif., June 28, 2024--Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
This biotech stock nears a buy point after an explosive move following positive drug trial news. Sales have grown by triple-digits for seven quarters.
Mirum (MIRM) posts positive interim data from two phase IIb studies evaluating volixibat in patients with primary biliary cholangitis and primary sclerosing cholangitis. Stock rises.